Sign in

CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company

Matinas BioPharma Holdings, Inc.

Sign in to watch
Ticker
MTNB
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463011414
Phone
908-484-8805
Business address
1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
  1. 8-K Event Regulation FD disclosure · Other events
  2. PRE 14A Proxy Proxy Statement (Preliminary)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Executive or director change · Regulation FD disclosure
  6. 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 8-K Event Results of operations
  13. 10-Q Report Quarterly Report
  14. 8-K Event Shareholder vote results
  15. 8-K Event Regulation FD disclosure · Other events
  16. 4 Grant or award Director acquired 20,725 shares (grant or award)
  17. DEF 14A Proxy Proxy Statement
  18. 3 Insider Initial Statement of Ownership
  19. 8-K Event Executive or director change · Other events
  20. 4 Open-market buy Director bought 20,000 shares at $0.83 ($16,600)

Page 13 of 29 · 576 filings